The landscape of dementia diagnosis has advanced dramatically with the appearance of refined biomarkers, such as amyloid PET scans, tau imaging, and blood-based assessments that will detect Alzheimer's pathology decades ahead of signs and symptoms arise. Whilst these technological advancements symbolize remarkable progress in being familiar with ne